These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

99 related items for PubMed ID: 974328

  • 1. Behavioural changes following olfactory bulbectomy in rats: a possible model for the detection of antidepressant drugs [proceedings].
    van Riezen H, Schnieden H, Wren A.
    Br J Pharmacol; 1976 Jul; 57(3):426P-427P. PubMed ID: 974328
    [No Abstract] [Full Text] [Related]

  • 2. Antidepressant-mediated reversal of abnormal behavior and neurodegeneration in mice following olfactory bulbectomy.
    Jarosik J, Legutko B, Unsicker K, von Bohlen Und Halbach O.
    Exp Neurol; 2007 Mar; 204(1):20-8. PubMed ID: 17059819
    [Abstract] [Full Text] [Related]

  • 3. A new animal model for the prediction of antidepressant activity.
    Wren A, van Riezen H, Rigter H.
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Mar; 10(2):96-100. PubMed ID: 616925
    [Abstract] [Full Text] [Related]

  • 4. Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist.
    Pałucha A, Brański P, Szewczyk B, Wierońska JM, Kłak K, Pilc A.
    Pharmacol Biochem Behav; 2005 Aug; 81(4):901-6. PubMed ID: 16040106
    [Abstract] [Full Text] [Related]

  • 5. The olfactory bulbectomised rat as a model of depression.
    Song C, Leonard BE.
    Neurosci Biobehav Rev; 2005 Aug; 29(4-5):627-47. PubMed ID: 15925697
    [Abstract] [Full Text] [Related]

  • 6. Locomotor sensitization to cocaine in rats with olfactory bulbectomy.
    Chambers RA, Sheehan T, Taylor JR.
    Synapse; 2004 Jun 01; 52(3):167-75. PubMed ID: 15065217
    [Abstract] [Full Text] [Related]

  • 7. The olfactory bulbectomized rat as a model of depression.
    Leonard BE.
    Pol J Pharmacol Pharm; 1984 Jun 01; 36(5):561-9. PubMed ID: 6099892
    [Abstract] [Full Text] [Related]

  • 8. The olfactory bulbectomized rat: a simple model for detecting drugs with antidepressant potential [proceedings].
    Cairncross KD, Cox B, Forster C, Wren AF.
    Br J Pharmacol; 1977 Nov 01; 61(3):497P. PubMed ID: 588843
    [No Abstract] [Full Text] [Related]

  • 9. Olfactory bulb ablation in the rat: behavioural changes and their reversal by antidepressant drugs.
    van Riezen H, Schnieden H, Wren AF.
    Br J Pharmacol; 1977 Aug 01; 60(4):521-8. PubMed ID: 907867
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological validation of a new test for the detection of antidepressant activity of drugs [proceedings].
    Rigter H, Van Riezen H, Wren A, Schnieden H.
    Br J Pharmacol; 1977 Mar 01; 59(3):451P-452P. PubMed ID: 843699
    [No Abstract] [Full Text] [Related]

  • 11. Potential antidepressants: pharmacology of 2-(4-methyl piperazin-1-yl)-1,8-naphthyridine-3-carbonitrile in rodent behavioural models.
    Mahesh R, Rajkumar R, Minasri B, Venkatesha Perumal R.
    Pharmazie; 2007 Dec 01; 62(12):919-24. PubMed ID: 18214343
    [Abstract] [Full Text] [Related]

  • 12. Effects of anxiolytic drugs on some behavioral consequences in olfactory bulbectomized rats.
    Wierońska JM, Papp M, Pilc A.
    Pol J Pharmacol; 2001 Dec 01; 53(5):517-25. PubMed ID: 11990071
    [Abstract] [Full Text] [Related]

  • 13. Antidepressant-like effects of serotonin type-3 antagonist, ondansetron: an investigation in behaviour-based rodent models.
    Ramamoorthy R, Radhakrishnan M, Borah M.
    Behav Pharmacol; 2008 Feb 01; 19(1):29-40. PubMed ID: 18195592
    [Abstract] [Full Text] [Related]

  • 14. Fengabine, a novel antidepressant GABAergic agent. I. Activity in models for antidepressant drugs and psychopharmacological profile.
    Lloyd KG, Zivkovic B, Sanger D, Depoortere H, Bartholini G.
    J Pharmacol Exp Ther; 1987 Apr 01; 241(1):245-50. PubMed ID: 3033203
    [Abstract] [Full Text] [Related]

  • 15. Behavioural changes induced by olfactory bulb ablation and intrabulbar injection of 5,6-DHT: susceptibility to psychotropic drugs [proceedings].
    Cairncross KD, Cox B, Kerwin R, Forster C, Wren AF.
    Br J Pharmacol; 1978 Mar 01; 62(3):400P-401P. PubMed ID: 638331
    [No Abstract] [Full Text] [Related]

  • 16. Tiagabine treatment is associated with neurochemical, immune and behavioural alterations in the olfactory bulbectomized rat model of depression.
    Pistovcakova J, Dostalek M, Sulcova A, Jezova D.
    Pharmacopsychiatry; 2008 Mar 01; 41(2):54-9. PubMed ID: 18311685
    [Abstract] [Full Text] [Related]

  • 17. Animal models used in prediction of antidepressant effects in man.
    Cooper BR, Howard JL, Soroko FE.
    J Clin Psychiatry; 1983 May 01; 44(5 Pt 2):63-6. PubMed ID: 6406466
    [Abstract] [Full Text] [Related]

  • 18. Effects of olfacotry bulbectomy and periphjerally-induced anosmia on thermoregulation in the rat: susceptibility to antidepressant type drugs.
    Forster C, Parkes J, Cox B.
    J Pharm Pharmacol; 1980 Sep 01; 32(9):630-4. PubMed ID: 6107364
    [No Abstract] [Full Text] [Related]

  • 19. Antidepressant-like effects of the delta-opioid receptor agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in an olfactory bulbectomized rat model.
    Saitoh A, Yamada M, Yamada M, Takahashi K, Yamaguchi K, Murasawa H, Nakatani A, Tatsumi Y, Hirose N, Kamei J.
    Brain Res; 2008 May 07; 1208():160-9. PubMed ID: 18381208
    [Abstract] [Full Text] [Related]

  • 20. Preclinical pharmacological actions of (+/-)-(1'R*,3R*)-3-phenyl-1- [1',2',3',4'-tetrahydro-5',6'-methylene-dioxy-1'-naphthalenyl) methyl] pyrrolidine methanesulfonate (ABT-200), a potential antidepressant agent that antagonizes alpha-2 adrenergic receptors and inhibits the neuronal uptake of norepinephrine.
    Hancock AA, Buckner SA, Giardina WJ, Brune ME, Lee JY, Morse PA, Oheim KW, Stanisic DS, Warner RB, Kerkman DJ.
    J Pharmacol Exp Ther; 1995 Mar 07; 272(3):1160-9. PubMed ID: 7891328
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.